The Effect of Mesenchymal Stem Cell Wharton’s Jelly on Nuclear Factor Kappa Beta and Interleukin-10 Levels in Osteoarthritis Rat Model

Vivi Sofia; Moch Saiful Bachri; Endrinaldi Endrinaldi

doi:10.3889/oamjms.2020.4465

Authors

Vivi Sofia Department of Pharmacology and Clinical Pharmacy, Ahmad Dahlan University, Jogjakarta, Indonesia
Moch Saiful Bachri Department of Pharmacology and Clinical Pharmacy, Ahmad Dahlan University, Jogjakarta, Indonesia
Endrinaldi Endrinaldi Department of Pharmacology and Clinical Pharmacy, Ahmad Dahlan University, Jogjakarta, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2020.4465

Keywords:

Nuclear factor kappa beta, Interleukin-10, Mesenchymal stem cell Wharton jelly, Osteoarthritis

Abstract

BACKGROUND: Osteoarthritis (OA) is a degenerative joint disease in one or more joints characterized by changes in pathological structures such as cartilage, hypertrophy, and remodeling of the subchondral bone and secondary inflammation of the synovium membrane, causing changes in joint components such as cells, matrices, and molecular production. At the molecular level, an imbalance between catabolic and anabolic activities in joint cartilage results in OA. Nuclear factor kappa beta (NFκβ) is a cytokine that plays an important role in the signaling pathway of the pathogenesis of OA in causing an inflammatory reaction, whereas interleukin (IL)-10 is an anti-inflammatory cytokine that is involved in the pathogenesis of OA.

AIM: This study aims to prove the influence before and after administration mesenchymal stem cells from Wharton’s jelly on the serum NFκβ and IL-10 levels in OA rat models.

MATERIALS AND METHODS: This research is an experimental study with the design of post-test-only control group design. The sample consisted of 16 OA rats as a control group and 16 OA rats treated with MSC-WJ as a treatment group. OA induction is done by injection of monosodium iodoacetate (MIA) into the intra-articular right knee. Giving MSC-WJ is done in the 3^rdweek after MIA induction. The serum NFκβ and IL-10 levels were measured after 3 weeks treated with MSC-WJ using the ELISA method. The statistical test used is an independent t-test. p < 0.05 was said to be statistically significant.

RESULTS: From the research results obtained, serum levels of knee OA of rat knee OA treated with mesenchymal stem cell Wharton jelly are lower than serum NFκβ levels of knee OA of the rat that is not treated, but the difference in levels of NFκβ is not significant (p > 0.05). The serum IL-10 level of rat OA of knee treated with mesenchymal stem cell Wharton jelly was higher than the serum IL-10 level of rat OA of the knee that was not treated, difference in levels of IL-10, is significant (p < 0.05).

CONCLUSION: This study concluded that MSC-WJ significantly decreased the serum NFκβ levels of OA rats and not significantly increased the serum IL-10 levels of OA rats.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Glyn-Jones S, Palmer AJ, Agricola R, Price AJ, Vincent TL, Weinans H, et al. Osteoarthritis. Lancet. 2015;386(9991):376- 87. https://doi.org/10.1016/s0140-6736(14)60802-3 PMid:25748615

Jeffries MA, Donica M, Baker LW, Stevenson ME, Annan AC, Humprey MB, et al. Genome-Wide DNA methylation study identifies significant epigenomic changes in osteoarthritis cartilage. Arthritis Rheumatol. 2014;66(10):2804-15. https://doi. org/10.1002/art.38762 PMid:24980887

Looser RF, Goldring SR, Scanzello CR, Goldring MB. Osteoarthritis. Arthriris Rheum J Rev. 2012;64(6):1697-707.

American Academy of Orthopaedic. Treatment of Osteoarthritis of the Knee. 2nd. Rosemont: American Academy of Orthopaedic Surgeons; 2013. https://doi. org/10.5435/00124635-201309020-00008

Miller LE 2nd, Li JF, Block JE. Quality of live in patients with knee osteoartritis; a commentary on nonsurgical and surgical treatments. Open Orthop J. 2013;7:619-23. PMid:24285987

Janusz MJ, Hookfin EB, Heitmeyer SA, Woessner JF, Freemont AJ, Hoyland JA, et al. Moderation of iodoacetate-induced osteoarthritis in rats by matrix metalloproteinase inhibitors. J Osteoarthritis Res Soc Int. 2001;9(8):751-60. https://doi.org/10.1053/joca.2001.0472 PMid:11795995

van Buul GM, Siebelt M, Leijs MJ, Bos PK, Waarsing JH, Kops N, et al. Mesenchymal stem cells reduce pain but not degenerative changes in a mono-iodoacetate rat model of osteoarthritis. J Orthop Res. 2014;32(9):1167-74. https://doi. org/10.1002/jor.22650 PMid:24839120

Javanmard MZ, Asgari D, Karimipour M, Atabaki F, Farjah G, Niakani A. Mesenchymal stem cells inhibit proteoglycan degeneration in a rat model of osteoarthritis. Gene Cell Tisue. 2015;2(4):e31011. https://doi.org/10.17795/gct-31011

Kuyinu EL, Narayanan G, Nair LS, Laurencin CT. Animal models of osteoarthritis: Classification, update, and measurement of outcomes. J Orthop Surg Res. 2016;11(19):1-27. https://doi. org/10.1186/s13018-016-0346-5 PMid:26837951

Matsumoto T, Cooper GM, Meszaros LB, Li G, Usas A, Fu FH, et al. Cartilage repair in a rat model of osteoarthritis through intraarticular transplantation of muscle-derived stem cells expressing bone morphogenetic protein 4 and soluble flt-1. J Am Coll Rheumatol. 2009;60(5):1390-406. https://doi.org/10.1002/ art.24443 PMid:19404941

Kim JS, Kroin JS, Buvanendran A, Li X, van Wijnen AJ, Tuman KJ, et al. Characterization of a new animal model for evaluation and treatment of back pain due to lumbar facet joint osteoarthritis. Arthritis Rheum. 2011;63(10):2966-73. https://doi. org/10.1002/art.30487 PMid:21953085

Endrinaldi. Pengaruh Pemberian Mesenchymal Stem Cells Wharton’s Jelly Terhadap Kadar Matrix Metalloproteinase-1, a-Disintegrin Like and Metalloproteinase with Thrombospondin Modif-4, Inducible Nitric Oxide Synthase dan Interleukin-4 Pada Tikus Model Osteoartritis, Disertasi; 2019.

Rigoglu S and Papavassiliou AG. The NFκβ signalling pathway in osteoarthritis. Int J Biochem Cell Biol. 2013;45(11):2580-4. PMid:24004831

Goldring MB. Articular Degradation in Osteoarthritis. Vol. 8. HSS Symposium Frontier in Ostearthritis; 2012. p. 7-9.

Kapoor M, Pelletier JM, Lajeunesse, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011;7(1):33-42. https://doi. org/10.1038/nrrheum.2010.196 PMid:21119608

Tornatore L, Thotakura AK, Benrett J, Morelti M, Franzoso G. The nuclear factor kappa beta signaling pathway: Integrating metabolism with inflammation. Trends Cell Biol. 2012;22(11):557- 66. https://doi.org/10.1016/j.tcb.2012.08.001 PMid:22995730

Chen X, Hu C, Wang G, Li L, Kong X, Ding Y. Nuclear factor kappa beta modulates osteogenesis of periodontal ligament stem cells through competition with beta catenin signaling in inflammatory microenvironments. Cell Death Dis. 2013;4(2):2510. https://doi. org/10.1038/cddis.2013.14 PMid:23449446

Boyce BF, Yao Z, Xing L. Functions of NF-κB in Bone. Ann N Y Acad Sci. 2010;1192:367-75. PMid:20392262

Guercio A, Marco PD, Casella S, Cannela V, Russoto L, Purpari G, et al. Production of canine mesenchymal stem cells from adipose tissue and their application in dogs with chronic osteoarthritis of the humeroradial joints. Cell Biol Int. 2012;36:189-94. https://doi.org/10.1042/cbi20110304 PMid:21936851

Chang J, Liu F, Lee M, Wu B, Ting K, Zara JN. NFκβ inhibits osteogenic differentiation of mesenchymal stem cells by promoting β-catenin degradation. Proc Natl Acad Sci U S A. 2013;110(23):9469-74. https://doi.org/10.1073/ pnas.1300532110 PMid:23690607

Luningschror P, Stocker B, Kaltschmidt B, Kaltschmidt C. miR- 290 cluster modulates pluripotency by repressing canonical NF-kappa B signaling. Stem Cells. 2012;30(4):655-64. https:// doi.org/10.1002/stem.1033 PMid:22232084

Yang HS, Park MJ, Yoon HI, Kim SY, Hang SH, Shin JY, et al. Soluble mediator from mesenchymal stem cells suppress T cell proliferation by inducing IL-10. Exp Mol Med. 2009;41(5):315- 24. https://doi.org/10.3858/emm.2009.41.5.035 PMid:19307751

Jung KJ, Lee GW, Park CH, Lee TJ, Kim JY, Sung EG. Mesenchymal stem cells decrease oxidative stress in bowels of interleukin-10 knock-out mice. Gut Liver. 2020;14(1):100-7. https://doi.org/10.5009/gnl18438 PMid:31158947

Maiti P, Peruzzaro F, Kolli N, Andrew M, Gharaibeh AA, Rossignol J. Transplantation of mesenchymal stem cells overexpressing interleukin-10 induces autophagy response and promotes neuroprotection in rat model of TBI. J Cell Mol Med. 2019;23(8):5211-24. https://doi.org/10.1111/jcmm.14396 PMid:31162801

Liu WH, Liu JJ, Wu J, Li Z, Liu F, Yin L, et al. Novel mechanism of inhibition of dendritic cells maturation by mesenchymal stem cells via interleukin-10 and the JAK 1/STAT 3 signaling pathway. PLoS One. 2013;8(1)e55487. https://doi.org/10.1371/journal. pone.0055487 PMid:23383203

Choi JJ, Yoo SA, Park SJ, Kang YJ, Kim WU, Oh IH. Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice. Clin Exp Immunol. 2008;153(2):269-76. https://doi.org/10.1111/j.1365-2249.2008.03683.x PMid:18713142

Nakajima M, Nito C, Sowa K, Suda S, Nishiyama Y, Takahashi AN, et al. Mesenchymal stem cells overexpressing interleukin-10 promote neuroprotection in experimental acute ischemic stroke. Mol Ther Methods Clin Dev. 2017;6:102-11. https://doi.org/10.1016/j.omtm.2017.06.005

PMid:28725658

Tallan MM, Mau F. Gambaran peningkatan kadar interleukin-10 (IL-10) dan tumor necrosis factor-alfa (TNF-α) dengan gejala klinis pada penderita malaria. Bull Health Res. 2016;44(3):181- 6. https://doi.org/10.22435/bpk.v44i3.4806.181-186